About
Tatiana Novobrantseva is the Chief Scientific Officer, Immuno-Oncology Research at Moderna. She attended the University of Cologne.
Position in the VCSift Database
- • 3 investors at Moderna are tracked.
- • 1 investors hold the Chief Scientific Officer, Immuno-Oncology Research role in VCSift. Tatiana Novobrantseva is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- US
Contact Information
linkedin.com/in/••••••••
Find more investors like Tatiana
Search Investors